Hardikkumar Jetani

发表

CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib

H. Einsele, M. Hudecek, J. Sierra, 2018, Leukemia.

Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia (AML).

H. Einsele, Marcos González, D. Mougiakakos, 2021, Blood.

Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia.

M. Hudecek, S. Danhof, J. Beckmann, 2018, Current research in translational medicine.

CAR T Cells Targeting FLT3 on AML Confer Potent Anti-Leukemic Activity and Act Synergistically with the FLT3 Inhibitor Midostaurin

H. Einsele, M. Hudecek, J. Sierra, 2017 .

Nucleic acid aptamers stabilize proteins against different types of stress conditions.

Ipsita Roy, N. Jain, I. Roy, 2014, Journal of pharmaceutical sciences.

Nucleic Acid Aptamers as Stabilizers of Proteins: The Stability of Tetanus Toxoid

N. Jain, I. Roy, Hardikkumar Jetani, 2013, Pharmaceutical Research.

Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia

A. Rosenwald, H. Einsele, M. Sauer, 2021, Communications biology.

Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia

A. Rosenwald, H. Einsele, R. Tibes, 2021, Communications Biology.

Nucleic Acid Aptamers as Stabilizers of Proteins: The Stability of Tetanus Toxoid

Ipsita Roy, N. Jain, I. Roy, 2013, Pharmaceutical Research.